Corbus Pharmaceuticals Holding Stock Price Prediction
| CRBP Stock | USD 17.82 0.18 1.02% |
Oversold Vs Overbought
33
Oversold | Overbought |
EPS Estimate Next Quarter (1.02) | EPS Estimate Current Year (4.20) | EPS Estimate Next Year (5.47) | Wall Street Target Price 59.5 | EPS Estimate Current Quarter (0.95) |
Using Corbus Pharmaceuticals hype-based prediction, you can estimate the value of Corbus Pharmaceuticals Holding from the perspective of Corbus Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Corbus Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Corbus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Corbus Pharmaceuticals after-hype prediction price | USD 18.12 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Corbus |
Corbus Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Corbus Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Corbus Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Corbus Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Corbus Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Corbus Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Corbus Pharmaceuticals' historical news coverage. Corbus Pharmaceuticals' after-hype downside and upside margins for the prediction period are 9.32 and 26.92, respectively. We have considered Corbus Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Corbus Pharmaceuticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of Corbus Pharmaceuticals is based on 3 months time horizon.
Corbus Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Corbus Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Corbus Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Corbus Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.15 | 8.80 | 0.30 | 0.09 | 12 Events / Month | 18 Events / Month | In about 12 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
17.82 | 18.12 | 1.68 |
|
Corbus Pharmaceuticals Hype Timeline
Corbus Pharmaceuticals is currently traded for 17.82. The entity has historical hype elasticity of 0.3, and average elasticity to hype of competition of -0.09. Corbus is forecasted to increase in value after the next headline, with the price projected to jump to 18.12 or above. The average volatility of media hype impact on the company the price is over 100%. The price gain on the next news is projected to be 1.68%, whereas the daily expected return is currently at -1.15%. The volatility of related hype on Corbus Pharmaceuticals is about 11891.89%, with the expected price after the next announcement by competition of 17.73. Net Loss for the year was (44.6 M) with loss before overhead, payroll, taxes, and interest of (16.14 M). Given the investment horizon of 90 days the next forecasted press release will be in about 12 days. Check out Corbus Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Corbus Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Corbus Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Corbus Pharmaceuticals' future price movements. Getting to know how Corbus Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Corbus Pharmaceuticals may potentially react to the hype associated with one of its peers.
Corbus Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Corbus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Corbus using various technical indicators. When you analyze Corbus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Corbus Pharmaceuticals Predictive Indicators
The successful prediction of Corbus Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Corbus Pharmaceuticals Holding, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Corbus Pharmaceuticals based on analysis of Corbus Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Corbus Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Corbus Pharmaceuticals's related companies. | 2023 | 2024 (projected) | Graham Number | 19.24 | 18.28 | Receivables Turnover | 1.37 | 1.31 |
Story Coverage note for Corbus Pharmaceuticals
The number of cover stories for Corbus Pharmaceuticals depends on current market conditions and Corbus Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Corbus Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Corbus Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Corbus Pharmaceuticals Short Properties
Corbus Pharmaceuticals' future price predictability will typically decrease when Corbus Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Corbus Pharmaceuticals Holding often depends not only on the future outlook of the potential Corbus Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Corbus Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.3 M | |
| Cash And Short Term Investments | 20.9 M |
Additional Tools for Corbus Stock Analysis
When running Corbus Pharmaceuticals' price analysis, check to measure Corbus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corbus Pharmaceuticals is operating at the current time. Most of Corbus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corbus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corbus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corbus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.